[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100317946":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":23,"locations":28,"responsibleParty":45,"collaborators":47,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":55,"acronym":10,"eligibilityCriteria":56,"healthyVolunteers":53,"sex":57,"minAge":58,"maxAge":59,"enrollmentInfo":60,"targetDuration":10,"studyType":63,"phases":10,"briefSummary":64,"conditions":65,"keywords":67,"overallStatus":30,"whyStopped":10,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"Children's Hospital of Philadelphia","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Cohort",null,"Critically ill child undergoing clinically indicated EEG monitoring and electrographic seizure management.",[13],"Other: Clinically indicated EEG monitoring.",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Clinically indicated EEG monitoring.","Children enrolled in the study will be undergoing clinically indicated EEG monitoring. Some children will undergo clinically indicated electrographic seizure management.",[9],[20],{"name":21,"affiliation":5,"role":22},"Nicholas S Abend, MD","PRINCIPAL_INVESTIGATOR",[24],{"name":21,"role":25,"phone":26,"phoneExt":10,"email":27},"CONTACT","215-590-1719","abend@chop.edu",[29],{"facility":5,"status":30,"city":31,"state":32,"zip":33,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"RECRUITING","Philadelphia","Pennsylvania","19104","United States","US",{"type":37,"coordinates":38},"Point",[39,40],-75.16362,39.95238,{"lat":40,"lon":39},[43],{"name":44,"role":25,"phone":26,"phoneExt":10,"email":10},"Nichoals S Abend, MD",{"type":46,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[48],{"name":49,"class":50},"National Institute of Neurological Disorders and Stroke (NINDS)","NIH","100317946","electrographic-seizure-management-and-neurobehavioral-outcomes-in-critically-ill-children-100317946",false,"NCT03419260","Electrographic Seizure Management and Neurobehavioral Outcomes in Critically Ill Children","Inclusion Criteria:\n\n1. Care in the Children's Hospital of Philadelphia Pediatric ICU.\n2. Clinically indicated continuous EEG monitoring.\n3. Age \\> 1 month to 18 years.\n\nExclusion Criteria:\n\n1. Admitted for Phase 2 (intracranial) EEG monitoring.\n2. Intensivist expects to discontinue technological support in the next two days given underlying medical or neurological problems.","ALL","1 Month","18 Years",{"count":61,"type":62},2500,"ESTIMATED","OBSERVATIONAL","Electrographic seizures are common in critically ill patients leading to increased use of resource-intense continuous EEG monitoring for seizure identification and management. When identified, electrographic seizures are generally treated with anti-seizure medications, but there are very limited data available regarding optimal treatment in terms of the efficacy or safety of specific anti-seizure medications or overall management strategies.\n\nThis is a single-center prospective observational study. The investigators aim to: (1) track critically ill patients undergoing clinically indicated EEG monitoring and seizure management to identify risk factors for electrographic seizures, (2) create prediction models guiding EEG monitoring resources to the patients at highest risk for seizures, and (3) evaluate our current management strategy in terms of safety.",[66],"Seizures",[68,69,70],"seizures","status epilepticus","EEG monitoring","2026-06-24",{"date":73,"type":74},"2026-06-29","ACTUAL",{"date":76,"type":74},"2017-03-13",{"date":78,"type":62},"2028-01-01",{"name":5,"class":6},1]